Aurora Innovation, Inc.
For the period ended Dec 31, 2025. Filed Feb 11, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 11, 2026
AUR$4.55-2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| Twelve Months EndedDecember 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash flows from operating activities | |||
| Net loss | $(816) | $(748) | $(796) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | 30 | 21 | 21 |
| Reduction in the carrying amount of right-of-use assets | 28 | 28 | 27 |
| Stock-based compensation | 188 | 144 | 160 |
| Change in fair value of derivative liabilities | (29) | 24 | 20 |
| Accretion of discount on investments | (11) | (28) | (28) |
| Other operating activities | — | (1) | — |
| Changes in operating assets and liabilities: | |||
| Other current and non-current assets | (9) | (22) | 1 |
| Operating lease liabilities | (29) | (26) | (25) |
| Other current and non-current liabilities | 67 | (3) | 22 |
| Net cash used in operating activities | (581) | (611) | (598) |
| Cash flows from investing activities | |||
| Purchases of property and equipment | (31) | (34) | (15) |
| Purchases of investments | (1,452) | (1,030) | (1,297) |
| Maturities and sales of investments | 1,238 | 892 | 1,320 |
| Net cash (used in) provided by investing activities | (245) | (172) | 8 |
| Cash flows from financing activities | |||
| Proceeds from issuance of common stock | 916 | 497 | 840 |
| Payments for taxes on net settlement of equity incentive awards | (79) | (2) | (7) |
| Other financing activities | (3) | (3) | (2) |
| Net cash provided by financing activities | 834 | 492 | 831 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 8 | (291) | 241 |
| Cash, cash equivalents, and restricted cash at beginning of the period | 227 | 518 | 277 |
| Cash, cash equivalents, and restricted cash at end of the period | $235 | $227 | $518 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.